What’s causing the GT Biopharma, Inc. (GTBP) stock to experience downfall?
GT Biopharma, Inc. (GTBP) has experienced a downfall of 5.91% in the aftermarket. However, the last trading session concluded at $3.72. Demonstration of Novel B7-H3
GT Biopharma, Inc. (GTBP) has experienced a downfall of 5.91% in the aftermarket. However, the last trading session concluded at $3.72. Demonstration of Novel B7-H3
Orbsat Corp. (OSAT) has seen a push of 7.26% in the aftermarket. However, the last trading session closed at $3.72 with a decrease of 4.86%.
Mmtec, Inc. (MTC) has seen an increase of 8.53% in the aftermarket. However, the last trading session closed at $0.783 with a decrease of 4.51%.
Oblong Inc. (OBLG) saw an increase of 5.50% in the aftermarket. However, the last trading session closed at $1.09 with a decrease of 6.03%. Third
Orion Group Holdings, Inc. (ORN) experienced a decrease of 6.88% in the aftermarket. However, the last trading session closed at $3.78 with an increase of
PLAYSTUDIOS, Inc. (MYPS) has seen an increase of 5.26% in the aftermarket. However, the last trading session closed at $4.18 with an increase of 7.73%.
Hycroft Mining Holding Corporation (HYMC) experienced an increase of 6.53% in the aftermarket. However, the last trading session closed at $0.6757 with a decrease of
Copyright©2024, Powered by Smart TechOne